| SENSEONICS HLGS.INC. NEW |
| USA |
| Gesundheit |
| US81727U3032 / A41MRZ |
| 6L60 (Frankfurt) / SENS (NASDAQ) |
| FRA:6L60, ETR:6L60, 6L60:GR, NASDAQ:SENS |
| - |
| https://www.senseonics.co.. |
|
Senseonics Holdings Inc. is a medical technology company focused on long-term implantable continuous glucose monitoring systems for people with diabetes. Its Eversense product line combines a small under-the-skin sensor, a removable smart transmitter..
>Volltext.. |
| 450.55 Mio. EUR |
| 380.27 Mio. EUR |
| 43.5 Mio. EUR |
| -95.43 Mio. EUR |
| -98.02 Mio. EUR |
| -2.04 EUR |
| 56.29 Mio. EUR |
| 40.38 Mio. EUR |
| -86.34 Mio. EUR |
| 5.79 |
| 96.62% |
| -65.41% |
| - |
| - |
| - |
| - |
| SENSEONICS |
| 01.11.26 |
|
||||
|